Literature DB >> 12740177

Mechanism underlying enhanced endothelium-dependent vasodilatation in thoracic aorta of early stage streptozotocin-induced diabetic mice.

Bing Shen1, Chun-Ling Ye, Kai-He Ye, Jian-Jun Liu.   

Abstract

AIM: To investigate the mechanism of the enhanced endothelium-dependent vasodilatation in thoracic aorta of the early stage streptozotocin (STZ)-induced diabetic C57BL/6J mice.
METHODS: Radioimmunity was used to detect the metabolite of prostaglandin I2 (PGI2), 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), in the blood serum. Vascular muscle tension and phenylephrine (PE)-induced rhythmic activity in the isolated thoracic aorta of mice were also compared.
RESULTS: 6-Keto-PGF1 alpha in the serum was significantly higher in STZ-induced diabetic mice than age-matched controls [(1.8+/-1.0) microg./L vs (0.5+/-0.3) microg/L, P<0.01]. PE induced rhythmic activity in both diabetic and control mouse aorta but the amplitude was markedly higher in diabetic mice than in controls [(4.9+/-1.7) % vs (12+/-5) %, P<0.01]. PE, high K+ solution-induced contraction, and acetylcholine (ACh)-induced relaxation [(56+/-10) % vs (81+/-8) %, P<0.01] were notably enhanced in diabetic mice than those in controls. Alone NG-nitro-L-arginine methyl ester (L-NAME) or 6-(phenylamino)-5,8-quinolinedione (LY-83583) abolished the rhythmic activity and ACh-induced relaxation in controls but only partially inhibited them in diabetic mice. Indomethacin did not affect rhythmic activity but depressed ACh-induced relaxation. L-NAME plus indomethacin significantly depressed the rhythmic activity and ACh-induced relaxation than L-NAME alone (P<0.01). Furthermore tetraethylammonium plus L-NAME abolished them in diabetic mice.
CONCLUSION: The mechanism that enhanced endothelium-dependent vasodilatation in STZ-induced diabetic mice is due to enhanced production of PGI2 and endothelium-derived hyperpolarizing factor (EDHF). The phenomena maybe only take place in early stage of diabetic mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740177

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  12 in total

Review 1.  Contribution of Rho-kinase and Adenosine Monophosphate-Activated Protein Kinase Signaling Pathways to Endothelium-Derived Contracting Factors Responses.

Authors:  Cennet Balcilar; Işıl Özakça; Vecdi Melih Altan
Journal:  Turk J Pharm Sci       Date:  2017-08-15

2.  Role of endothelium-dependent hyperpolarisation and prostacyclin in diabetes.

Authors:  Siti Safiah Mokhtar; Aida Hanum Ghulam Rasool
Journal:  Malays J Med Sci       Date:  2015 Mar-Apr

3.  Imperatorin is responsible for the vasodilatation activity of Angelica Dahurica var. Formosana regulated by nitric oxide in an endothelium-dependent manner.

Authors:  Hong Nie; Lan-zhen Meng; Jiu-yao Zhou; Xiao-feng Fan; Yong Luo-; Guang-wen Zhang
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

4.  Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes.

Authors:  A Joshi; O L Woodman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-09-11       Impact factor: 3.000

5.  Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries.

Authors:  A MacKenzie; E J Cooper; F J Dowell
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

6.  Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: a shift in the relative importance of EDRFs.

Authors:  Rui Zhang; Der Thor; Xiaoyuan Han; Leigh Anderson; Roshanak Rahimian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

7.  Doxorubicin-induced vasomotion and [Ca(2+)](i) elevation in vascular smooth muscle cells from C57BL/6 mice.

Authors:  Bing Shen; Chun-ling Ye; Kai-he Ye; Lan Zhuang; Jia-hua Jiang
Journal:  Acta Pharmacol Sin       Date:  2009-10-12       Impact factor: 6.150

8.  Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes.

Authors:  Hooi Hooi Ng; Chen Huei Leo; Darnel Prakoso; Chengxue Qin; Rebecca H Ritchie; Laura J Parry
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

9.  Reduced up-regulation of the nitric oxide pathway and impaired endothelial and smooth muscle functions in the female type 2 diabetic goto-kakizaki rat heart.

Authors:  Martine Desrois; Carole Lan; Jamileh Movassat; Monique Bernard
Journal:  Nutr Metab (Lond)       Date:  2017-01-13       Impact factor: 4.169

10.  Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI2 : a safer alternative to COX-2 inhibition.

Authors:  Gulsev Ozen; Ingrid Gomez; Armond Daci; Catherine Deschildre; Lilia Boubaya; Onder Teskin; B Sonmez Uydeş-Doğan; Per-Johan Jakobsson; Dan Longrois; Gokce Topal; Xavier Norel
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.